“…Up to now, exosomes from various cell sources have been used to promote wound healing in diabetes. Stem cells are the most studied, including adipose stem cells (ADSCs) ( 11 , 17 , 28 , 31 , 35 , 38 , 40 – 47 ), bone marrow mesenchymal stem cells (BMSCs) ( 15 , 16 , 23 , 26 , 32 , 33 , 37 , 44 , 48 – 51 ), human umbilical cord-derived mesenchymal stem cells (hUCMSCs) ( 27 , 52 , 53 ), synovium mesenchymal stem cells (SMSCs) ( 18 , 21 ), gingival mesenchymal stem cells (GMSCs) ( 39 ), human urine-derived stem cells (USCs) ( 22 ), menstrual blood-derived mesenchymal stem cells (MenSCs) ( 36 ), placental mesenchymal stem cells (PMSCs) ( 54 ), human endometrial stem cells (hEnSCs) ( 34 ), hair follicle-derived mesenchymal stromal cells ( 55 ), epidermal stem cells (ESCs) ( 56 , 57 ). Other cells, like fibrocytes ( 58 ), human umbilical cord blood endothelial progenitor cells ( 19 , 59 ), human umbilical cord blood mononuclear cells (hUCBMNCs) ( 30 ), macrophages ( 24 ), human amniotic epithelial cells ( 25 ), dermal fibroblasts (DFs) ( 14 ), M2 macrophages ( 60 ), human umbilical vein endothelial cells (HUVECs) ( 61 ), also were used for exosome isolation.…”